Back

drs. U.V.V. (Frank ) Kreek

drs. U.V.V. (Frank ) Kreek

Full Professor

Show full profile

Research Output (516)

Inhibition of PCSK9 Synthesis via RNA Interference: 90 Day Data From Orion-1-a Multi-Centre Phase-2 Randomized Controlled Trial

Ray Kausik K., Landmesser Ulf, Leiter Lawrence A., Kallend David, Wijngaarcr Peter, Dufour Robert, Hall Timothy, Karakas Mahir, Turner Traci, Visseren Frank L., Wright'' R. S., Kastelein John J. 20 Dec 2016, In: Circulation. 134 , p. E705-E705

The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease

van Kruijsdijk Rob C M, van der Graaf Yolanda, Algra Ale, de Borst Gert Jan, Cramer Maarten J., Siersema Peter D., Peeters Petra H M, Visseren Frank L J, Doevendans P. A., Algra A., van der Graaf Y., Grobbee D. E., Rutten G. E H M, Kappelle L. J., Leiner T., Moll F. L., Visseren F. L J 13 Dec 2016, In: Journal of the American College of Cardiology. 68 , p. 2588-2589 2 p.

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

van der Leeuw Joep, Visseren Frank L J, Woodward Mark, van der Graaf Yolanda, Grobbee Diederick E., Harrap Stephen, Heller Simon, Mancia Giuseppe, Marre Michel, Poulter Neil, Zoungas Sophia, Chalmers John Dec 2016, In: Diabetologia. 59 , p. 2603–2612 10 p.

Prevalence and severity of arterial calcifications in pseudoxanthoma elasticum (PXE) compared to hospital controls. Novel insights in to the vascular phenotype of PXE

Kranenburg Guido, de Jong Pim A, Mali Willem P, Attrach Mohamed, Visseren Frank L J, Spiering Wilko 13 Nov 2016, In: Atherosclerosis. 256 , p. 7-14 8 p.

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population

Kaasenbrood Lotte, Boekholdt S. Matthijs, Van Der Graaf Yolanda, Ray Kausik K., Peters Ron J G, Kastelein John J P, Amarenco Pierre, Larosa John C., Cramer Maarten J M, Westerink Jan, Kappelle L. Jaap, De Borst Gert J., Visseren Frank L J 8 Nov 2016, In: Circulation. 134 , p. 1419-1429 11 p.

Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes

Franssens Bas T. , Westerink Jan, van der Graaf Yolanda, Nathoe Hendrik M., Visseren Frank L J 1 Nov 2016, In: International Journal of Cardiology. 222 , p. 72-77 6 p.

Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.

van der Sande NGC, Dorresteijn JAN, Visseren FLJ, Dwyer J.P., Blankestijn p, van der Graaf Y, Heerspink H. J Lambers Nov 2016, In: Diabetes, Obesity & Metabolism. 18 , p. 1120-1127

Response to Comment on Sharif et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 2016;39:1424–1430

Sharif Shahnam, Van Der Graaf Yolanda, Nathoe Hendrik M., de Valk Harold W., Visseren Frank L J, Westerink Jan 1 Oct 2016, In: Diabetes Care. 39 , p. e190-e191

Tendon xanthomas:Not always familial hypercholesterolemia

Koopal Charlotte, Visseren Frank L J, Marais A David, Westerink Jan, Spiering Wilko 30 Sep 2016, In: Journal of Clinical Lipidology. 10 , p. 1262-5 4 p.

Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease

van den Berg M Johanneke, van der Graaf Yolanda, de Borst Gert Jan, Kappelle L Jaap, Nathoe Hendrik M, Visseren Frank L J, 15 Sep 2016, In: American Journal of Cardiology. 118 , p. 804-810 7 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not